×

Mallinckrodt CEO Celebrates Spinoff

9:47 AM ET Mon, 1 July 2013

Marc Trudeau, Mallinckrodt Pharmaceuticals CEO, talks with CNBC about his company's debut on the NYSE and discusses various growth products in its pipeline.